Status:
COMPLETED
Remote Ischemic Postconditioning During Percutaneous Coronary Interventions
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Angioplasty is a commonly performed procedure for treating blockage of the blood vessels in the heart. Although this procedure is usually successful, it is often accompanied by a small degree of damag...
Eligibility Criteria
Inclusion
- Patients scheduled for PCI
Exclusion
- Acute myocardial infarction
- Myocardial infarction or coronary bypass surgery during the last 4 weeks before PCI
- Use of Glyburide
- Heart failure (NYHA III/IV)
- Chronic inflammatory disease
- Severe renal impairment
- Significant peripheral vascular disease
- Unsuitable for use of an embolic protection device for PCI to SVG
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00970827
Start Date
May 1 2009
End Date
June 1 2014
Last Update
September 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sceinces Centre
London, Ontario, Canada, N6A5A5